TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 OVERVIEW
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING RESEARCH & DEVELOPMENT EXPENDITURE
4.2.2 RISING DRUG DEVELOPMENT OUTSOURCING
4.3 RESTRAINTS
4.3.1 STRINGENT REGULATORY POLICIES AND COSTS ASSOCIATED TO DRUG DISCOVERY
4.4 OPPORTUNITY
4.4.1 TECHNOLOGICAL ADVANCEMENTS IN DRUG DISCOVERY
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 CUSTOMER ACQUISITION (PREPURCHASE QUERY)
5.1.2 SERVICE CUSTOMIZATION
5.1.2.1 R&D
5.1.2.2 GOOD LABORATORY PRACTICES (GLP)
5.1.3 CUSTOMER PURCHASE SUPPORT
5.1.4 CUSTOMER FULFILMENT & POST-PURCHASE SUPPORT
5.2 PORTER’S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
5.3 COVID-19 IMPACT ON THE DRUG DISCOVERY SERVICES MARKET
5.3.1 IMPACT ON R&D
5.3.2 IMPACT ON PRICING
5.3.3 IMPACT ON MARKET GROWTH
6 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE
6.1 OVERVIEW
6.2 SMALL MOLECULE DRUG
6.3 BIOLOGICS DRUG
7 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES
7.1 OVERVIEW
7.2 DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES
7.3 PHARMACEUTICAL SERVICES
7.4 MEDICINAL CHEMISTRY
7.5 BIOLOGICAL SERVICES
7.6 MEDICATION
8 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA
8.1 OVERVIEW
8.2 ONCOLOGY
8.3 CARDIOVASCULAR DISEASES
8.4 RESPIRATORY DISEASES
8.5 DIABETES
8.6 OTHERS
9 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY
9.1 OVERVIEW
9.2 HIGH THROUGHPUT SCREENING
9.3 BIOCHIPS
9.4 PHARMACOGENOMICS AND PHARMACOGENETICS
9.5 METABOLOMICS
9.6 OTHERS
10 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY END USER
10.1 OVERVIEW
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.3 RESEARCH & ACADEMIC INSTITUTES
10.4 OTHERS
11 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY REGION
11.1 OVERVIEW
11.2 NORTH AMERICA
11.2.1 US
11.2.2 CANADA
11.3 EUROPE
11.3.1 GERMANY
11.3.2 FRANCE
11.3.3 UK
11.3.4 ITALY
11.3.5 SPAIN
11.3.6 REST OF EUROPE
11.4 ASIA-PACIFIC
11.4.1 CHINA
11.4.2 JAPAN
11.4.3 INDIA
11.4.4 AUSTRALIA
11.4.5 SOUTH KOREA
11.4.6 REST OF ASIA-PACIFIC
11.5 REST OF THE WORLD
11.5.1 MIDDLE EAST
11.5.2 AFRICA
11.5.3 LATIN AMERICA
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 COMPETITIVE BENCHMARKING
12.3 MAJOR GROWTH STRATEGY IN DRUG DISCOVERY SERVICES MARKET
12.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN DRUG DISCOVERY SERVICES MARKET
12.5 KEY DEVELOPMENTS & GROWTH STRATEGIES
12.5.1 SERVICE LAUNCH
12.5.2 MERGERS & ACQUISITIONS
12.5.3 PARTNERSHIP/COLLABORATION
12.6 MAJOR PLAYERS SALES ANALYSIS
12.6.1 SALES & OPERATING INCOME, 2021 (USD MILLION)
12.6.2 MAJOR PLAYERS R&D ANALYSIS, 2021 (USD MILLION)
13 COMPANY PROFILE
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 COMPANY OVERVIEW
13.1.2 FINANCIAL OVERVIEW
13.1.3 SERVICES OFFERED
13.1.4 KEY DEVELOPMENTS
13.1.5 SWOT ANALYSIS
13.1.6 KEY STRATEGIES
13.2 ARAGEN LIFE SCIENCES PVT. LTD.
13.2.1 COMPANY OVERVIEW
13.2.2 FINANCIAL OVERVIEW
13.2.3 SERVICES OFFERED
13.2.4 KEY DEVELOPMENTS
13.2.5 KEY STRATEGIES
13.3 PIRAMAL PHARMA SOLUTIONS
13.3.1 COMPANY OVERVIEW
13.3.2 FINANCIAL OVERVIEW
13.3.3 SERVICES OFFERED
13.3.4 KEY DEVELOPMENTS
13.3.5 KEY STRATEGIES
13.4 CURIA GLOBAL, INC.
13.4.1 COMPANY OVERVIEW
13.4.2 FINANCIAL OVERVIEW
13.4.3 SERVICES OFFERED
13.4.4 KEY STRATEGIES
13.5 CHARLES RIVER LABORATORIES
13.5.1 COMPANY OVERVIEW
13.5.2 FINANCIAL OVERVIEW
13.5.3 SERVICES OFFERED
13.5.4 KEY DEVELOPMENTS
13.5.5 SWOT ANALYSIS
13.5.6 KEY STRATEGIES
13.6 EUROFINS SCIENTIFIC
13.6.1 COMPANY OVERVIEW
13.6.2 FINANCIAL OVERVIEW
13.6.3 SERVICES OFFERED
13.6.4 KEY DEVELOPMENTS
13.6.5 SWOT ANALYSIS
13.6.6 KEY STRATEGIES
13.7 IQVIA
13.7.1 COMPANY OVERVIEW
13.7.2 FINANCIAL OVERVIEW
13.7.3 SERVICES OFFERED
13.7.4 KEY DEVELOPMENTS
13.7.5 SWOT ANALYSIS
13.7.6 KEY STRATEGIES
13.8 EVOTEC
13.8.1 COMPANY OVERVIEWS
13.8.2 FINANCIAL OVERVIEW
13.8.3 SERVICES OFFERED
13.8.4 KEY DEVELOPMENTS
13.8.5 KEY STRATEGIES
13.9 WUXI APPTEC CO., LTD.
13.9.1 COMPANY OVERVIEW
13.9.2 FINANCIAL OVERVIEW
13.9.3 SERVICES OFFERED
13.9.4 KEY DEVELOPMENTS
13.9.5 SWOT ANALYSIS
13.9.6 KEY STRATEGIES
13.10 LABORATORY CORPORATION OF AMERICA HOLDINGS
13.10.1 COMPANY OVERVIEW
13.10.1 FINANCIAL OVERVIEW
13.10.2 SERVICES OFFERED
13.10.3 KEY DEVELOPMENTS
13.10.4 KEY STRATEGIES
13.11 SELVITA
13.11.1 COMPANY OVERVIEW
13.11.2 FINANCIAL OVERVIEW
13.11.3 SERVICES OFFERED
13.11.4 KEY DEVELOPMENTS
13.11.5 SWOT ANALYSIS
13.11.6 KEY STRATEGIES
13.12 SYGNATURE DISCOVERY
13.12.1 COMPANY OVERVIEW
13.12.2 FINANCIAL OVERVIEW
13.12.3 SERVICES OFFERED
13.12.4 KEY DEVELOPMENTS
13.12.5 SWOT ANALYSIS
13.12.6 KEY STRATEGIES
13.13 SYMERES
13.13.1 COMPANY OVERVIEW
13.13.2 FINANCIAL OVERVIEW
13.13.3 SERVICES OFFERED
13.13.4 KEY DEVELOPMENTS
13.13.5 SWOT ANALYSIS
13.13.6 KEY STRATEGIES
13.14 NUCHEM SCIENCES INC.
13.14.1 COMPANY OVERVIEW
13.14.2 FINANCIAL OVERVIEW
13.14.3 SERVICES OFFERED
13.14.4 KEY STRATEGIES
13.15 PARAZA PHARMA, INC.
13.15.1 COMPANY OVERVIEW
13.15.2 FINANCIAL OVERVIEW
13.15.3 SERVICES OFFERED
13.15.4 KEY DEVELOPMENTS
13.15.5 KEY STRATEGIES
14 APPENDIX
14.1 REFERENCES
14.2 RELATED REPORTS
LIST OF TABLESTABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
TABLE 3 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 4 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR SMALL MOLECULE DRUG, BY REGION, 2023-2030 (USD MILLION)
TABLE 5 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR BIOLOGICS DRUG, BY REGION, 2023-2030 (USD MILLION)
TABLE 6 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2023-2030 (USD MILLION)
TABLE 7 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES, BY REGION, 2023-2030 (USD MILLION)
TABLE 8 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR PHARMACEUTICAL SERVICES, BY REGION, 2023-2030 (USD MILLION)
TABLE 9 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR MEDICINAL CHEMISTRY, BY REGION, 2023-2030 (USD MILLION)
TABLE 10 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR BIOLOGICAL SERVICES, BY ERGION, 2023-2030 (USD MILLION)
TABLE 11 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR MEDICATION, BY REGION, 2023-2030 (USD MILLION)
TABLE 12 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 13 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR ONCOLOGY, BY REGION, 2023-2030 (USD MILLION)
TABLE 14 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR CARDIOVASCULAR DISEASES, BY REGION, 2023-2030 (USD MILLION)
TABLE 15 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR RESPIRATORY DISEASES, BY REGION, 2023-2030 (USD MILLION)
TABLE 16 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR DIABETES, BY REGION, 2023-2030 (USD MILLION)
TABLE 17 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR OTHERS, BY REGION, 2023-2030 (USD MILLION)
TABLE 18 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 19 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR HIGH THROUGHPUT SCREENING COMPANIES, BY REGION, 2023-2030 (USD MILLION)
TABLE 20 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR BIOCHIPS, BY REGION, 2023-2030 (USD MILLION)
TABLE 21 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR PHARMACOGENOMICS AND PHARMACOGENETICS, BY REGION, 2023-2030 (USD MILLION)
TABLE 22 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR METABOLOMICS, BY REGION, 2023-2030 (USD MILLION)
TABLE 23 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR OTHERS, BY REGION, 2023-2030 (USD MILLION)
TABLE 24 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR END USER, BY REGION, 2023-2030 (USD MILLION)
TABLE 25 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
TABLE 26 LOBAL DRUG DISCOVERY SERVICES MARKET, FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
TABLE 27 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR OTHERS, BY REGION, 2023-2030 (USD MILLION)
TABLE 28 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 29 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 30 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 31 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2023-2030 (USD MILLION)
TABLE 32 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 33 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 34 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 35 US: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 36 US: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)
TABLE 37 US: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 38 US: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 39 US: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 40 CANADA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 41 CANADA: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)
TABLE 42 CANADA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 43 CANADA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 44 CANADA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 45 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 46 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 47 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)
TABLE 48 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 49 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 50 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 51 GERMANY: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 52 GERMANY: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)
TABLE 53 GERMANY: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 54 GERMANY: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 55 GERMANY: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 56 FRANCE: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 57 FRANCE: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)
TABLE 58 FRANCE: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 59 FRANCE: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 60 FRANCE: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 61 UK: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 62 UK: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)
TABLE 63 UK: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 64 UK: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 65 UK: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 66 ITALY: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 67 ITALY: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)
TABLE 68 ITALY: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 69 ITALY: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 70 ITALY: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 71 SPAIN: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 72 SPAIN: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)
TABLE 73 SPAIN: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 74 SPAIN: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 75 SPAIN: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 76 REST OF EUROPE: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 77 REST OF EUROPE: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)
TABLE 78 REST OF EUROPE: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 79 REST OF EUROPE: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 80 REST OF EUROPE: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 81 ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 82 ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 83 ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)
TABLE 84 ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 85 ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 86 ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 87 CHINA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 88 CHINA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)
TABLE 89 CHINA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 90 CHINA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 91 CHINA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 92 JAPAN: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 93 JAPAN: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)
TABLE 94 JAPAN: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 95 JAPAN: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 96 JAPAN: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 97 INDIA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 98 INDIA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)
TABLE 99 INDIA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 100 INDIA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 101 INDIA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 102 AUSTRALIA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 103 AUSTRALIA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)
TABLE 104 AUSTRALIA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 105 AUSTRALIA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 106 AUSTRALIA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 107 SOUTH KOREA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 108 SOUTH KOREA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)
TABLE 109 SOUTH KOREA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 110 SOUTH KOREA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 111 SOUTH KOREA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 112 REST OF ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 113 REST OF ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)
TABLE 114 REST OF ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 115 REST OF ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 116 REST OF ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 117 REST OF THE WORLD: DRUG DISCOVERY SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 118 REST OF THE WORLD: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 119 REST OF THE WORLD: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)
TABLE 120 REST OF THE WORLD: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 121 REST OF THE WORLD: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 122 REST OF THE WORLD: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 123 MIDDLE EAST: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 124 MIDDLE EAST: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)
TABLE 125 MIDDLE EAST: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 126 MIDDLE EAST: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 127 MIDDLE EAST: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 128 AFRICA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 129 AFRICA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)
TABLE 130 AFRICA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 131 AFRICA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 132 AFRICA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 133 LATIN AMERICA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 134 LATIN AMERICA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)
TABLE 135 LATIN AMERICA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 136 LATIN AMERICA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 137 LATIN AMERICA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 138 MAJOR MANUFACTURERS IN DRUG DISCOVERY SERVICES MARKET
TABLE 139 MOST ACTIVE PLAYER IN DRUG DISCOVERY SERVICES MARKET
TABLE 140 SERVICE LAUNCH
TABLE 141 MERGERS & ACQUISITIONS
TABLE 142 PARTNERSHIP/COLLABORATION
TABLE 143 THERMO FISHER SCIENTIFIC INC.: SERVICES OFFERED
TABLE 144 ARAGEN LIFE SCIENCES PVT. LTD.: SERVICES OFFERED
TABLE 145 ARAGEN LIFE SCIENCES PVT.: KEY DEVELOPMENTS
TABLE 146 PIRAMAL PHARMA SOLUTIONS: SERVICES OFFERED
TABLE 147 CURIA GLOBAL, INC.: SERVICES OFFERED
TABLE 148 CURIA GLOBAL, INC.: KEY DEVELOPMENTS
TABLE 149 CHARLES RIVER LABORATORIES: SERVICES OFFERED
TABLE 150 CHARLES RIVER LABORATORIES: KEY DEVELOPMENTS
TABLE 151 EUROFINS SCIENTIFIC: SERVICES OFFERED
TABLE 152 EUROFINS SCIENTIFIC: KEY DEVELOPMENTS
TABLE 153 IQVIA: SERVICES OFFERED
TABLE 154 EVOTEC: SERVICES OFFERED
TABLE 155 EVOTEC: KEY DEVELOPMENTS
TABLE 156 WUXI APPTEC CO., LTD.: SERVICES OFFERED
TABLE 157 WUXI APPTEC CO., LTD.: KEY DEVELOPMENTS
TABLE 158 LABORATORY CORPORATION OF AMERICA HOLDINGS: SERVICES OFFERED
TABLE 159 SELVITA: SERVICES OFFERED
TABLE 160 SELVITA: KEY DEVELOPMENTS
TABLE 161 SYGNATURE DISCOVERY: SERVICES OFFERED
TABLE 162 SYGNATURE DISCOVERY: KEY DEVELOPMENTS
TABLE 163 SYMERES: SERVICES OFFERED
TABLE 164 SYMERES: KEY DEVELOPMENTS
TABLE 165 NUCHEM SCIENCES INC.: SERVICES OFFERED
TABLE 166 NUCHEM SCIENCES INC.: KEY DEVELOPMENTS
TABLE 167 PARAZA PHARMA, INC.: SERVICES OFFERED
| ※参考情報 創薬サービスは、薬剤の研究開発プロセスを支援するための多様なサービスや技術を指します。これは、新しい医薬品を発見し、開発するための複雑な過程であり、さまざまな専門分野の知識と技術が運用されます。創薬サービスは、製薬企業、バイオテクノロジー企業、大学の研究機関などが利用しており、創薬の各段階での効率性を向上させ、新薬の市場投入までの期間を短縮することを目的としています。 創薬サービスにはいくつかの種類があります。最初に、スクリーニングサービスがあります。これは膨大な化合物ライブラリの中から活性を持つ化合物を検索するために使用される技術で、ハイスループットスクリーニングやバイオアッセイなどが含まれます。次に、ヒット化合物の最適化を目指すリード最適化サービスがあります。これにより、ヒット化合物の構造を修正し、選択性、薬物動態、毒性を改善することができます。 さらに、前臨床研究サービスも重要な役割を果たします。これは、治験に入る前に、候補化合物の生物学的特性、安全性、効果を評価する過程を指します。動物モデルを用いて行われることが多く、化合物の有効性を証明するための試験が含まれます。また、クリニカルトライアルのデザインや管理を行う臨床開発サービスもあります。 創薬サービスの用途は多岐にわたります。新薬の発見・開発において、これらのサービスを利用することで、薬剤候補の探索や最適化が迅速かつ効率的に行えます。また、創薬サービスは医薬品の規制要件に対応するためにも利用され、製品の承認を得るためのデータを提供します。さらに、新たな疾患に対する治療法を見つけるためのターゲット発見や、既存の薬剤の新たな適応症を探るためのリサーチにも役立ちます。 それに伴って、関連技術も進化しています。例えば、高速化した自動化技術やAI（人工知能）を活用したデータ解析技術は、創薬プロセスを加速する上で重要な役割を果たしています。AIは、大量の生物学的データや化合物データを解析し、有望な候補を予測するために活用されることが増えています。また、コンピュータシミュレーションや分子モデリング技術も、化合物の性質や相互作用の理解を助けるために使用されています。 さらに、オミクス技術（ゲノミクス、プロテオミクス、メタボロミクス等）は、創薬の各段階でのターゲット発見やメカニズムの解明に寄与しています。これにより、特定の疾患に対する分子標的を特定し、その効果を最大化するアプローチが可能となります。結局のところ、創薬サービスはライフサイエンス産業の基盤を支える重要な要素であり、より革新的で安全な医薬品の開発に向けた大きな一助となっています。 最後に、創薬業界は国際的な協力が不可欠です。製薬企業や研究機関は情報を共有し、共同研究を行うことで、より迅速かつ効果的に新薬の開発を進めています。特に、最近のパンデミックの影響を受けて、創薬サービスの迅速な展開が求められ、国際的な連携の重要性が再認識されました。このように、創薬サービスは生命科学の進歩に寄与し、人々の健康と福祉を向上させるための重要な役割を担っています。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
